Cargando…
A commentary on ‘development and validation of safety and efficacy-associated risk calculator for hepatocellular carcinoma in the elderly after resection (searcher): a multi-institutional observational study’ (Int J Surg 2022;106:106842)
Autores principales: | Huo, Teh-Ia, Ho, Shu-Yein, Liao, Jia-I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389528/ https://www.ncbi.nlm.nih.gov/pubmed/36799853 http://dx.doi.org/10.1097/JS9.0000000000000012 |
Ejemplares similares
-
Responses to commentary on ‘Efficacy and safety of neoadjuvant immunotherapy in surgically resectable esophageal cancer: a systematic review and meta-analysis’ (Int J Surg 2022;106:106929)
por: Wang, Zhaoyang, et al.
Publicado: (2023) -
A commentary on ‘Nomograms for predicting the recurrence probability and recurrence-free survival in patients with hepatocellular carcinoma after conversion hepatectomy based on hepatic arterial infusion chemotherapy: a multicenter, retrospective study’ (Int J Surg 2023; 109:1299–310)
por: Huo, Teh-Ia, et al.
Publicado: (2023) -
Commentary on “The Ukrainian refugee crisis and the COVID-19 pandemic in Europe” (Int J Surg 2022;102:106671)
por: Sriwitalai, Won, et al.
Publicado: (2022) -
A commentary on “The 2022 monkeypox outbreak: Lessons from the 640 cases in 36 countries” (Int J Surg 2022;104:106712)
por: Sookaromdee, Pathum, et al.
Publicado: (2022) -
A commentary on ‘Burnout in surgeons: A qualitative investigation into contributors and potential solutions’ (Int J Surg 2022;101:106613)
por: Li, Ziwei, et al.
Publicado: (2023)